CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)		Total		Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020				13,914,731
Beginning balance at Dec. 31, 2020		$ 79,328,671		$ 1,375	$ 137,249,496	$ (57,125,635)	$ (796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net (in shares)				1,750,000
Issuance of common stock, net		114,087,891		$ 175	114,087,716
Stock-based compensation, net of forfeitures		406,488			406,488
Shares issued for exercise/vesting of stock-based compensation awards (in shares)				13,356
Shares issued for exercise/vesting of stock-based compensation awards		30,452			30,452
Net income (loss)		(6,576,038)				(6,576,038)
Ending balance (in shares) at Mar. 31, 2021				15,678,087
Ending balance at Mar. 31, 2021		187,277,464		$ 1,550	251,774,152	(63,701,673)	(796,565)
Beginning balance (in shares) at Dec. 31, 2020				13,914,731
Beginning balance at Dec. 31, 2020		79,328,671		$ 1,375	137,249,496	(57,125,635)	(796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity method investments income in other comprehensive income (loss), net of tax	[1]	73,975
Net income (loss)		(25,070,369)
Ending balance (in shares) at Sep. 30, 2021				15,869,395
Ending balance at Sep. 30, 2021		171,045,224		$ 1,560	253,962,258	(82,196,004)	(722,590)
Beginning balance (in shares) at Mar. 31, 2021				15,678,087
Beginning balance at Mar. 31, 2021		187,277,464		$ 1,550	251,774,152	(63,701,673)	(796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures		611,808			611,808
Shares issued for exercise/vesting of stock-based compensation awards (in shares)				81,446
Shares issued for exercise/vesting of stock-based compensation awards		185,699			185,699
Equity method investments income in other comprehensive income (loss), net of tax		(31,288)					(31,288)
Conversion of performance rights (in shares)				5,000
Net income (loss)		(7,632,972)				(7,632,972)
Ending balance (in shares) at Jun. 30, 2021				15,764,533
Ending balance at Jun. 30, 2021		180,410,711		$ 1,550	252,571,659	(71,334,645)	(827,853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures		833,509			833,509
Shares issued for exercise/vesting of stock-based compensation awards (in shares)				104,862
Shares issued for exercise/vesting of stock-based compensation awards		557,100		$ 10	557,090
Equity method investments income in other comprehensive income (loss), net of tax		105,263	[1]				105,263
Net income (loss)		(10,861,359)				(10,861,359)
Ending balance (in shares) at Sep. 30, 2021				15,869,395
Ending balance at Sep. 30, 2021		171,045,224		$ 1,560	253,962,258	(82,196,004)	(722,590)
Beginning balance (in shares) at Dec. 31, 2021				15,894,395
Beginning balance at Dec. 31, 2021		161,784,606		$ 1,589	255,131,836	(92,683,000)	(665,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net (in shares)				2,012,500
Issuance of common stock, net		122,059,476		$ 201	122,059,275
Stock-based compensation, net of forfeitures		(85,908)			(85,908)
Shares issued for exercise/vesting of stock-based compensation awards (in shares)				22,631
Shares issued for exercise/vesting of stock-based compensation awards		0		$ 3	(3)
Equity method investments income in other comprehensive income (loss), net of tax		193,644					193,644
Net income (loss)		(9,154,632)				(9,154,632)
Ending balance (in shares) at Mar. 31, 2022				17,929,526
Ending balance at Mar. 31, 2022		274,797,186		$ 1,793	377,105,200	(101,837,632)	(472,175)
Beginning balance (in shares) at Dec. 31, 2021				15,894,395
Beginning balance at Dec. 31, 2021		161,784,606		$ 1,589	255,131,836	(92,683,000)	(665,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity method investments income in other comprehensive income (loss), net of tax	[1]	662,178
Net income (loss)		(2,071,054)
Ending balance (in shares) at Sep. 30, 2022				17,994,576
Ending balance at Sep. 30, 2022		285,384,358		$ 1,799	380,140,254	(94,754,054)	(3,641)
Beginning balance (in shares) at Mar. 31, 2022				17,929,526
Beginning balance at Mar. 31, 2022		274,797,186		$ 1,793	377,105,200	(101,837,632)	(472,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures		1,591,231			1,591,231
Shares issued for exercise/vesting of stock-based compensation awards (in shares)				35,337
Shares issued for exercise/vesting of stock-based compensation awards		93,326		$ 3	93,323
Equity method investments income in other comprehensive income (loss), net of tax		(342,767)					(342,767)
Net income (loss)		(9,581,303)				(9,581,303)
Ending balance (in shares) at Jun. 30, 2022				17,964,863
Ending balance at Jun. 30, 2022		266,557,673		$ 1,796	378,789,754	(111,418,935)	(814,942)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures		1,350,503			1,350,503
Shares issued for exercise/vesting of stock-based compensation awards (in shares)				29,713
Shares issued for exercise/vesting of stock-based compensation awards		0		$ 3	(3)
Equity method investments income in other comprehensive income (loss), net of tax		811,301	[1]				811,301
Net income (loss)		16,664,881				16,664,881
Ending balance (in shares) at Sep. 30, 2022				17,994,576
Ending balance at Sep. 30, 2022		$ 285,384,358		$ 1,799	$ 380,140,254	$ (94,754,054)	$ (3,641)

[1] Equity method investments income in other comprehensive income (loss) is presented net of tax expense of $391,796 for the three and nine months ended September 30, 2022. We did not reflect a tax expense during the three and nine months ended September 30, 2021 because we had a full tax valuation allowance in impacted jurisdictions during these periods.